US22978P2056
US22978P2056
Cue Biopharma, Inc.
Loading chart...
Pure Price Volatility Risk (Market Swings)
The business itself is financially solid (Financial Health 52/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±124.5% p.a.) and steep historical drawdowns.
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves approx. 2.6x as much as the broader market.
Beta (Market Relation)
2.63x
Above averageVolatility (5Y p.a.)
124.5% p.a.
5-Year HorizonMax Drawdown (5Y)
-99.0%
5-Year HorizonSharpe Ratio
-0.37
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Volatility Expansion (3Y > 5Y) High Volatility
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | -13.2% |
| 3 Years | 146.6% | -94.3% | -0.21 | -28.5% |
| 5 Years | 124.5% | -99.0% | -0.37 | -43.7% |
| 10 Years | 105.5% | -99.4% | -0.28 | — |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
High market risk: Beta of 2.63 indicates above-average volatility compared to the broader market.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (146.6%) is noticeably higher than the 5Y average (124.5%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (124.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -99.4% in the extended horizon.
Corporate Governance & ISS Scores
Overall Governance Risk
7 ISS Score: 7 / 10
Audit Risk
9 ISS Score: 9 / 10
Board Risk
9 ISS Score: 9 / 10
Short Ratio
2.05